The Ritedose Corporation Revenue and Competitors

Location

#9293

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • The Ritedose Corporation's estimated annual revenue is currently $69.3M per year.(i)
  • The Ritedose Corporation's estimated revenue per employee is $201,000

Employee Data

  • The Ritedose Corporation has 345 Employees.(i)
  • The Ritedose Corporation grew their employee count by 8% last year.

The Ritedose Corporation's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
VP Technical ServicesReveal Email/Phone
3
EVP QualityReveal Email/Phone
4
VP OperationsReveal Email/Phone
5
VP, Scientific AffairsReveal Email/Phone
6
Associate Director Regulatory & Compliance Controlled SubstancesReveal Email/Phone
7
Director Quality AssuranceReveal Email/Phone
8
Director Human ResourcesReveal Email/Phone
9
Director Business ApplicationReveal Email/Phone
10
Sr. Director Quality AssuranceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M390%N/AN/A
#2
$1.7M410%$82.4MN/A
#3
$102.7M5111%N/AN/A
#4
$7M356%N/AN/A
#5
$12.3M61-12%N/AN/A
#6
$410.8M2044-7%N/AN/A
#7
$48.6M2427%N/AN/A
#8
$14.7M730%N/AN/A
#9
$9M45-12%N/AN/A
#10
$10.7M534%N/AN/A
Add Company

What Is The Ritedose Corporation?

The Ritedose Corporation is a leader in blow-fill-seal(BFS) manufacturing of small fill volume pharmaceutical unit dose sterile and non-sterile liquids. We specialize in manufacturing inhalation products, eye drops, eardrops and unit dose oral liquids.

keywords:N/A

N/A

Total Funding

345

Number of Employees

$69.3M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Ritedose Corporation News

2022-04-17 - Blow Fill Seal Equipment Market Size And Forecast ...

Unipharma, Catalent, The Ritedose Corporation, Recipharm, Pharmapack, Curida, Weiler Engineering, Unicep Packaging, Unither Pharmaceuticals...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$96M3495%N/A
#2
$35M3538%N/A
#3
$92.9M354-15%N/A
#4
$15M35822%N/A
#5
$113.3M36114%N/A